Silfurberg A

Cancer treatment and cardio-toxicity

Moderator: Þ. J Hrafnkelsdóttir, MD PhD, Iceland, and M. Elmet, MD, Estonia

Cardiotoxicity: the oncologist's perspective

A. Smáradottir, MD, Iceland

What do the guidelines tell us?

N. Lang, MD PhD, UK

9:30

Reaching the label of top10 best hospitals in the world.

Dr B. Zoëga, MD PhD, Sweden

Silfurberg B

The autonomic nervous system

Moderator: E. Rinkuniene, MD, Lithuania, and M. R. Schmidt, MD PhD, Denmark

ANS dysfunction and postural orthostatic tachycardia syndrome post COVID

A. Fedorowski, MD PhD, Sweden

POTS - A clinician‘s perspective

S. Guðmundsson, MD, Iceland

Sleep, Death and the Heart - Autonomic Neural Mechanisms 

V. Somers, MD PhD, USA

Ríma A + B

The young (at heart) cardiologist

Moderator: H. Agnarsson, MD, Iceland

Hands-on-ECG

H. Agnarsson, MD, Iceland

Electrophysiology for the Non-Electrophysiologist

K. Guðmundsson, MD, Iceland

Silfurberg A

Chronic heart failure

Moderators: A. Rafnsson, MD PhD, Iceland, and O. C. Mjølstad, MD PhD, Norway

The Icelandic Heart Failure Registry and clinical HF research

I. J. Ingimarsdóttir, MD PhD, Iceland

STRONG-HF - concept of chemotherapy for HF

Jelena Celutkiene, MD PhD, Lithuania

New therapies in HFpEF

Dan Atar, MD PhD, Norway

Silfurberg B

Heart and sleep

Moderators: H.M. Skúladóttir, MD, Iceland and A. Erglis, MD, PhD, Latvia

Treatment of sleep apnea in the cardiac patient; Clinical pearls and pitfalls

J. Cunningham, MD, Iceland

The future of sleep apnea diagnostics

E.S. Arnardóttir, PhD, Iceland

The importance of incorporating  cardiovascular parameters in sleep diagnostics - signal analytical approach

S. Kainulainen, PhD, Finland

Sleep and Belly FAt- You Lose Some, You Gain Some

V. Somers, MD PhD, USA

Ríma A + B

The young (at heart) cardiologist

Moderator: J. Hlebowicz, MD PhD, Sweden, and J. Badariene, MD PhD, Lithuania

„The kids are getting older“ -  everything a fellow needs to know about ACHD

M.R. Schmidt, MD PhD, Denmark

„Why the future is prevention“ - everything a fellow needs to know about lipids

A.Sigurðsson, MD PhD, Iceland and K.Ray, MD PhD, UK

Silfurberg A

Hypertrophic cardiomyopathy

Moderator: G. Þ. Gunnarsson, MD PhD, Iceland, and M. Elmet, MD, Estonia

The peek-and-boo left ventricular outflow tract obstruction gradient

B. Aðalsteinsdóttir, MD PhD, Iceland

Family screening and follow-up in hypertrophic cardiomyopathy

J. Mogensen, MD PhD, Denmark

Advances in personalized treatment of LVOT obstruction. (ONLINE)

I. Olivotto, MD PhD, Italy

Silfurberg B

Arrhythmias and risk assessment

Moderator: D. O. Arnar, MD PhD, Iceland, and A. Erglis, MD PhD, Latvia

Ventricular Tachycardia - causes and pathophysiology

K. Guðmundsson, MD, Iceland

Syncope – a pragmatic approach

A. Fedorowski, MD PhD, Sweden

ICD treatment in 2023

F. Braunschweig, MD PhD, Sweden

Ríma A + B

The young (at heart) cardiologist

Moderators: H. Agnarsson, MD, Iceland

Hands-on-haemodynamics, simulation and so much more

M. Broomé, MD PhD, Sweden

Silfurberg A

Secondary prevention

Moderator: K. Andersen, MD PhD, Iceland, and D. Atar, MD PhD, Norway

Clinical CAD cases - a journey through the decades

B. Libungan, MD PhD, Iceland

Are we achieving our goals?

M. Leósdóttir MD PhD, Sweden

Lipids, combination lipid-lowering therapy vs step-wise approach- time to be pragmatic

K. Ray, MD PhD, UK

Silfurberg B

Percutaneous valve interventions, new frontiers

Moderator: M. Niemelä, MD PhD, Finland, and I. J. Guðmundsdóttir, MD PhD

Simulation of valvular disease 

M. Broomé, MD PhD, Sweden

Considerations regarding lifetime management of a patient referred for TAVI

G. Bieliauskas, MD, Denmark

Minimal invasive mitral OP

P. Wierup, MD PhD, Sweden

Ríma A + B

The young (at heart) cardiologist

Moderator: G. Þ. Gunnarsson, MD PhD, Iceland and K. Trusinskis, MD PhD, Latvia

Clinical cases presentation

Clinical cases awards

Ríma A + B

ECG Quiz

Moderators: H.R. Agnarsson,  MD, Iceland and H.Saarinen, MD, Finland

Silfurberg A + B

Cardiovascular prevention and epidemiology; New insights from the Icelandic Heart Association

Moderator: C. Held, MD PhD, Sweden, and R. Slapikas, MD PhD, Lithuania

Improved CV risk assessment by adding imaging

V. Guðnason, MD PhD,  Iceland

New insights from omics data in cardiovascular risk assessment

V. Guðmundsdóttir, PhD,  Iceland

Relation of educational attainment with subclinical atherosclerosis

K. Andersen, MD PhD, Iceland

Trends in STEMI and NSTEMI diagnoses during 35 years - a total population perspective in Iceland

S. Bjarnadóttir, MD, Iceland

The impact of population based interventions vs statins in cholesterol lowering over 25 years

B. Þórsson, MD, Iceland

Silfurberg A + B

European Heart Journal‘s year in cardiovascular medicine

Moderator: Marco Roffi, Co-editor of EHJ, MD PhD, Switzerland, Gunnar Þór Gunnarsson, MD PhD, Iceland

Cardiovascular risk factors - prevention

K Andersen, MD Phd, Iceland

Coronary artery disease

EHJ speaker Marco Roffi, MD PhD, Switzerland

Imaging

K Trusinskis, MD PhD, Latvia

Heart failure

EHJ speaker Dan Atar, MD PhD, Norway